Skip to main content
. 2006 Feb 28;94(6):798–805. doi: 10.1038/sj.bjc.6603011

Table 1. Patients characteristics.

  FOLFIRI (n=146)
FOLFOXIRI (n=137)
Characteristics n % n %
Age
 Median (range) 66 (39–84) 66 (25–82)
 ⩾65 years 82 56 75 55
         
Sex
 Male 82 58 76 55
 Female 61 42 61 45
         
Performance status (ECOG)
 0 55 38 49 36
 1 74 51 73 53
 2 17 11 15 11
         
Localisation
 Colon 110 75 100 73
 Rectum 36 25 37 27
         
Sites of disease
 Liver 102 70 99 72
 Lung 46 32 42 31
 Other 63 43 61 46
         
Number of metastatic sites
 1 59 40 55 40
 2 63 43 57 42
 ⩾3 24 16 25 18
 Median (range) 2 (1–4) 2 (1–6)
         
Metastases
 Synchronous 63 43 66 48
 Metachronous 83 57 70 52
         
Kohne prognostic index
 Low risk 54 37 44 32
 Intermediate risk 57 39 56 41
 High risk 35 24 37 27
         
Prior therapy
 Adjuvant chemotherapy 48 33 49 36
 Adjuvant   18   17
 Chemoradiotherapy   12   12